Archived AES Symposia 2006
Legal Aspects of Epilepsy Care Symposium
Program Length: 2 hrs 33 min
Review of accumulated information from prior AES meetings has contained medical-legal matters as a concern of the membership. Adverse drug effects cause liability and our membership makes their interests clear that they want more information. Driving issues and associated liability are listed frequently as a source of interest. Following a previous CME program in the AET symposium, there was enthusiastic endorsement of content that focused on legal aspects of adverse drug effects.
At the conclusion of this activity, participants should be able to:
- Given that epilepsy and treatments affect many patients’ ability to drive, educate the physician on the history of driving laws, the differences in driving laws from state to state and, most importantly, the physician’s role in helping the patient to understand these rules
- Given that many epilepsy patients frequently encounter employment related issues, summarize the American with Disabilities Act and how this affects patients’ legal rights so that both the physician and patient may be prepared when an employment obstacle arises
- Given that physicians routinely use the PDR, recognize the legal reasons for following this reference manual, to improve documentation of potential adverse effects of AEDs in their patients
- Given that persons with epilepsy are often stigmatized by their communities, use tools to educate communities and protect patients from the myth that epilepsy is linked to violent behavior, so that the patient is not stigmatized.
Neurologists, nurses, psychiatrists and other healthcare professionals involved in the care of persons with epilepsy.
Co-chairs: L. James Willmore, M.D. and David M. Labiner, M.D.
Medical-Legal Aspects of Adverse Drug Effects
L. James Willmore, M.D.
Family and Criminal Law
David M. Labiner, M.D.
Employment Law/Americans with Disabilities Act
Alexandra Finucane, J.D.
Violence and Epilepsy
David M. Treiman, M.D.
Lori Uber-Zak, D.O.
Panel Discussion: Conversion to Generics
Peter Wolfe, M.D., Ph.D. and symposium faculty.
Disclaimer: Opinions expressed with regard to unapproved uses of products are solely those of the faculty and are not endorsed by the American Epilepsy Society or any manufacturers of pharmaceuticals.